News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CYCN market cap is 5.04M. The company's latest EPS is USD -18.0271 and P/E is -0.11.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 306k | 0 | 608k | 0 | 0 |
| Operating Income | -13.43M | -10.61M | -7.35M | -7.04M | -4.24M |
| Net Income | -13.39M | -10.5M | -7.22M | -6.95M | -4.18M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 4.51M | 3.97M | 3.94M | 1.63M |
| Operating Income | -115.25M | -125.04M | -81.27M | -55.2M | -44.37M |
| Net Income | -115.25M | -123.01M | -77.8M | -51.65M | -44.08M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 35.21M | 25.05M | 18.08M | 11.46M | 10.1M |
| Total Liabilities | 9.85M | 8.53M | 7.63M | 7.53M | 4.95M |
| Total Equity | 25.36M | 16.52M | 10.45M | 3.93M | 5.15M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.4M | 186.48M | 115.38M | 59.33M | 18.08M |
| Total Liabilities | 17.85M | 88.75M | 55.89M | 11.09M | 7.63M |
| Total Equity | -10.45M | 97.73M | 59.49M | 48.25M | 10.45M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.65M | -33.57M | -40.61M | -6.21M | -12.77M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 17k | 17k | 29k | N/A | 5.02M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -97.5M | -102.22M | -72.49M | -36.52M | -40.61M |
| Investing | -3.44M | -6.72M | 18k | 1.46M | N/A |
| Financing | 100.94M | 211.57M | 28.09M | 30.79M | 29k |
| Market Cap | 5.04M |
| Price to Earnings Ratio | -0.11 |
| Price to Sales Ratio | 3.1 |
| Price to Cash Ratio | 0.38 |
| Price to Book Ratio | 0.48 |
| Dividend Yield | - |
| Shares Outstanding | 2.45M |
| Average Volume (1 week) | 3.99k |
| Average Volume (1 Month) | 4.43k |
| 52 Week Change | -87.81% |
| 52 Week High | 19.664 |
| 52 Week Low | 1.7501 |
| Spread (Intraday) | 0.33 (15.14%) |
| Company Name | Cyclerion Therapeutics Inc |
| Address |
155 federal street boston, massachusetts 02110 |
| Website | https://www.cyclerion.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
